Bovine malignant catarrhal fever explained

Bovine malignant catarrhal fever (BMCF) is a fatal lymphoproliferative disease[1] caused by a group of ruminant gamma herpes viruses including Alcelaphine gammaherpesvirus 1 (AlHV-1)[2] and Ovine gammaherpesvirus 2 (OvHV-2)[3] These viruses cause unapparent infection in their reservoir hosts (sheep with OvHV-2 and wildebeest with AlHV-1), but are usually fatal in cattle and other ungulates such as deer, antelope, and buffalo.[2] In Southern Africa the disease is known as snotsiekte, from the Afrikaans.[4] [5]

BMCF is most prevalent in areas where reservoir and susceptible animals mix. There is a particular problem with Bali cattle in Indonesia,[6] bison in the US[7] and in pastoralist herds in Eastern and Southern Africa.[8] [9]

Disease outbreaks in cattle are usually sporadic, although infection of up to 40% of a herd has been reported. The reasons for this are unknown. Some species appear to be particularly susceptible, for example Père David's deer,[10] Bali cattle[6] and bison,[7] with many deer dying within 48 hours of the appearance of the first symptoms and bison within three days.[11] In contrast, post infection cattle will usually survive a week or more.[12]

Epidemiology

The term bovine malignant catarrhal fever has been applied to three different patterns of disease:

The incubation period of BMCF is not known, however intranasal challenge with AHV-1 induced MCF in one hundred percent of challenged cattle between 2.5 and 6 weeks.[25] Shedding of the virus is greater from 6–9 month old lambs than from adults. After experimental infection of sheep, there is limited viral replication in the nasal cavity in the first 24 hours after infection, followed by later viral replication in other tissues.

Clinical signs

The most common form of the disease is the head and eye form. Typical symptoms of this form include fever, depression, discharge from the eyes and nose, lesions of the buccal cavity and muzzle, swelling of the lymph nodes, opacity of the corneas leading to blindness, inappetence and diarrhea. Some animals have neurologic signs, such as ataxia, nystagmus, and head pressing. Animals that become infected with the virus can become extremely sensitive to touch, especially around the head. It is also possible that become aggressive and charge at approaching animals and people. If the virus continues untreated, seizures could develop. Affected animal usually die five to ten days of the first signs of clinical signs. Once the cow shows clinical signs there is no chance of recovering.[26]

Fulminant, alimentary and cutaneous clinical disease patterns have also been described.[27] Death usually occurs within ten days.[28] The mortality rate in symptomatic animals is 90 to 100% Treatment is supportive only.

Factors

There are many factors that can increase the chances of infection or affect the severity of an outbreak. The number of animals in the herd, population density and species of the susceptible hosts are huge factors. Other factors include closeness of contact and amount of virus available for transmission.[29]

Diagnosis

Diagnosis of BMCF depends on a combination of history and symptoms, histopathology[27] and detection in the blood or tissues of viral antibodies by ELISA[30] [31] or of viral DNA by PCR.[22] [32] [33] The characteristic histologic lesions of MCF are lymphocytic arteritis with necrosis of the blood vessel wall and the presence of large T lymphocytes mixed with other cells. The similarity of MCF clinical signs to other enteric diseases, for example blue tongue, mucosal disease and foot and mouth make laboratory diagnosis of MCF important.[34] The World Organisation for Animal Health[27] recognises histopathology as the definitive diagnostic test, but laboratories have adopted other approaches with recent developments in molecular virology.

AlHV-1 and OvHV-2 are almost indistinguishable without molecular sequencing. However Anderson et al 2008 do find some usable differences, mostly necrosis or lack of necrosis, and lymphoid accumulation.

Life cycle

Infection of T cells is typical of MCF group viruses. This was discovered by Nelson et al. 2010 by experimental infection of Bison bison with ovine strains. They additionally found B lymphocytes to be present but irrelevant in MCF lesions.

Ovine

Ovine strains have been investigated by Meier-Trummer et al. 2009 (OvHV-2 experimentally in rabbits) and Nelson et al. 2013 (SA-MCF experimentally in Bison bison), both finding these to be lytic viruses.[35]

Bovine

Bison

Bison bison are found by Nelson et al. 2010 to suffer widespread mucosal necrosis but rarely occlusive thrombosis, and they judge thrombosis to be hardly able to explain the incidence of necrosis.

Nelson also find CD8 and CD3 to be the most common immune cell types in lesions.

Bos

CD8 and CD4 are the most common immune cell types in lesions found by Nelson et al. 2010.

Prognosis

Bovine malignant catarrhal fever is usually fatal in susceptible species like cattle and bison, and any animal that survives will remain infectious for the rest of its life even if it shows no subsequent signs of the disease. Survivors may relapse and suffer attacks in later life. Latent infections may go unrecognised until recurrence, explaining signs of disease in animals with no known history of contact with reservoir species.

Vaccine

A vaccine for malignant catarrhal fever (MCF) has not yet been developed. Developing a vaccine has been difficult, as the virus does not grow in cell cultures, and until recently, it was not known why this is. Researchers at the Agricultural Research Service (ARS) found that the virus undergoes changes within the animal's body, a process known as cell tropism switching. In cell tropism switching, the virus targets different cells at different points in its life cycle. This phenomenon explains why it has been impossible to grow the virus on any one particular cell culture. Because the virus is transmitted from sheep to bison and cattle, researchers are first focusing on the viral life cycle in sheep. The viral life cycle is outlined in three stages: entry, maintenance, and shedding. Entry occurs through the sheep's nasal cavity and enters into the lungs where it replicates. The virus undergoes a tropic change and infects lymphocytes, also known as white blood cells, which play a role in the sheep's immune system. In the maintenance stage the virus remains on the sheep's lymphocytes and circulates the body. Finally, during the shedding stage, the virus undergoes another change and shifts its target cells from lymphocytes to nasal cavity cells, where it is then shed through nasal secretions.[36] This discovery puts scientists closer to developing a vaccine – starting with the correct cell culture for each stage of the virus lifecycle – but ARS researchers are also looking into alternative methods to develop a vaccine. Researchers are experimenting with the MCF virus that infects topi (an African antelope) because it will grow in cell culture and does not infect cattle. Researchers hope that inserting genes from the sheep MCF virus into the topi MCF virus will ultimately be an effective MCF vaccine for cattle and bison.[36]

External links

Notes and References

  1. 10.1177/0300985813520435 . 24503439 . The Pathology of Malignant Catarrhal Fever, with an Emphasis on Ovine Herpesvirus 2 . . ACVP ECVP JCVP (Sage) . 51 . 2 . 437–452 . 2014 . o'Toole . D. . Li . H.. free .
  2. 10.1038/1881167a0 . 13736396 . Blue Wildebeest and the Ætiological Agent of Bovine Malignant Catarrhal Fever . Nature . 188 . 4757 . 1167–1169 . 1960 . Plowright . W. . Ferris . R. D. . Scott . G. R. . 1960Natur.188.1167P. 37101022 .
  3. 10.1177/104063870001200602 . 11108448 . Epizootic Malignant Catarrhal Fever in Three Bison Herds: Differences from Cattle and Association with Ovine Herpesvirus-2 . Journal of Veterinary Diagnostic Investigation . 12 . 6 . 497–502 . 2000 . Schultheiss . Patricia C. . Collins . James K. . Spraker . Terry R. . Demartini . James C.. free .
  4. Book: Elizabeth S. Williams . Ian K. Barker . Infectious Diseases of Wild Mammals . 28 February 2008 . John Wiley & Sons . 978-0-470-34481-1 . 157–.
  5. Book: . Martha H. Talbot . The Wildebeest in Western Masailand, East Africa . 1963 . National Academies . 52– . NAP:13180.
  6. 7839584 . 1994 . Wiyono . A. . PCR detection of ovine herpesvirus-2 DNA in Indonesian ruminants--normal sheep and clinical cases of malignant catarrhal fever . Veterinary Microbiology . 42 . 1 . 45–52 . Baxter . S. I. . Saepulloh . M. . Damayanti . R. . Daniels . P. . Reid . H. W.. 10.1016/0378-1135(94)90076-0 .
  7. 10.1177/104063870501700110 . 15690951 . An Outbreak of Sheep-Associated Malignant Catarrhal Fever in Bison (Bison Bison) after Exposure to Sheep at a Public Auction Sale . Journal of Veterinary Diagnostic Investigation . 17 . 1 . 55–58 . 2005 . Berezowski . John Andrew . Appleyard . Greg D. . Crawford . Timothy B. . Haigh . Jerry . Li . Hong . Middleton . Dorothy M. . O'Connor . Brendan P. . West . Keith . Woodbury . Murray. 43134613 .
  8. Web site: Cleaveland S . Kusiluka L . Ole Kuwai J . Bell C . Kazwala R. . 2001 . Assessing the impact of Malignant Catarrhal Fever in Ngorongoro District, Tanzania.. 57–72. Animal Health Programme, Department for International Development. PDF. 9 September 2020.
  9. 10.1016/j.prevetmed.2006.10.012 . 17123651 . Maasai perception of the impact and incidence of malignant catarrhal fever (MCF) in southern Kenya . Preventive Veterinary Medicine . 78 . 3–4 . 296–316 . 2007 . Bedelian . Claire . Nkedianye . David . Herrero . Mario.
  10. 10.1080/00480169.1988.35466 . 16031426 . An outbreak of malignant catarrhal fever in Père David's deer (Elaphurus davidianus) . New Zealand Veterinary Journal . 36 . 1 . 19–21 . 1988 . Orr . M.B. . MacKintosh . C.G..
  11. 10.1177/104063870201400301 . 12033673 . Malignant Catarrhal Fever in a Bison (Bison Bison) Feedlot, 1993–2000 . Journal of Veterinary Diagnostic Investigation . 14 . 3 . 183–193 . 2002 . O'Toole . D. . Li . H. . Sourk . C. . Montgomery . D. L. . Crawford . T. B.. free .
  12. 10.1136/vr.161.14.494-e . 17921444 . Malignant catarrhal fever in cattle in the UK . Veterinary Record . 161 . 14 . 494–495 . 2007 . Holliman . A. . Daniel . R. . Twomey . D. F. . Barnett . J. . Scholes . S. . Willoughby . K. . Russell . G.. 26446432 .
  13. Mushi . E. Z. . Rurangirwa . F. R. . Bulletin of Animal Health and Production in Africa . 1981 . 29 . 1 . 111–2 . Malignant catarrhal fever virus shedding by infected cattle . 7296019 .
  14. Baxter . S. I. . Wiyono . A. . Pow . I. . Reid . H. W. . Identification of Ovine Herpes Virus-2 infection in sheep . Archives of Virology . 142 . 4 . 1997 . 823–831 . 10.1007/s007050050121 . 9170507 . 30143095 .
  15. Book: Barnard . B. J. . Van der Lugt . J. J. . Mushi . E. Z. . Malignant Catarrhal Fever . J. A. W. . Coetzer . G. R. . Thompson . R. C. . Tustin . Infectious Diseases of Livestock . Oxford University Press . New York . 1994 . 978-0-19-570506-5 .
  16. Homewood . K. H. . Rodgers . W. A. . Arhem . K. . Ecology of pastoralism in Ngorongoro Conservation Area, Tanzania . The Journal of Agricultural Science . 108 . 1987 . 47–72 . 10.1017/S0021859600064133 . 86547027 .
  17. Boone . R. B. . Coughenour . M. B. . 2001 . A system for integrated management and assessment of east African pastoral lands. Balancing food security, wildlife conservation, and ecosystem integrity . Final report to the Global Livestock Collaborative Research Support Program.
  18. Book: Fenner . Frank J. . Gibbs . E. . Paul . J. . Murphy . Frederick A. . Rott . Rudolph . Studdert . Michael J. . White . David O. . Veterinary Virology . 2nd . Academic Press . 1993 . 978-0-12-253056-2 .
  19. 10.1354/vp.44-5-655 . 17846237 . Intra-nasal Inoculation of American Bison (Bison bison) with Ovine Herpesvirus-2 (OvHV-2) Reliably Reproduces Malignant Catarrhal Fever . Veterinary Pathology . 44 . 5 . 655–662 . 2007 . O'Toole . D. . Taus . N. S. . Montgomery . D. L. . Oaks . J. L. . Crawford . T. B. . Li . H.. 7232660 .
  20. 10.1099/vir.0.82285-0 . 17170434 . Comparison of ovine herpesvirus 2 genomes isolated from domestic sheep (Ovis aries) and a clinically affected cow (Bos bovis) . Journal of General Virology . 88 . Pt 1 . 40–45 . 2007 . Taus . N. S. . Herndon . D. R. . Traul . D. L. . Stewart . J. P. . Ackermann . M. . Li . H. . Knowles . D. P. . Lewis . G. S. . Brayton . K. A.. free .
  21. Web site: 2005 . Malignant Catarrhal fever . The Center for Food Security and Public Health at Iowa State University . 2006-05-13.
  22. 10.1128/CDLI.8.1.123-128.2001 . 11139205 . 96020 . Quantitative Fluorogenic PCR Assay for Measuring Ovine Herpesvirus 2 Replication in Sheep . Clinical and Vaccine Immunology . 8 . 1 . 123–128 . 2001 . Hussy . D. . Stauber . N. . Leutenegger . C. M. . Rieder . S. . Ackermann . M..
  23. 10.1638/2007-0181.1 . 18817000 . Development of a Management Program for a Mixed Species Wildlife Park Following an Occurrence of Malignant Catarrhal Fever . Journal of Zoo and Wildlife Medicine . 39 . 3 . 380–385 . 2008 . Cooley . A. Jim . Taus . Naomi S. . Li . Hong. 24137474 .
  24. 18309750 . 2216446 . 2008 . Li . H. . Long distance spread of malignant catarrhal fever virus from feedlot lambs to ranch bison . The Canadian Veterinary Journal . 49 . 2 . 183–5 . Karney . G. . O'Toole . D. . Crawford . T. B..
  25. 10.1016/j.vaccine.2008.06.056 . 18601965 . An immunisation strategy for the protection of cattle against alcelaphine herpesvirus-1-induced malignant catarrhal fever . Vaccine . 26 . 35 . 4461–4468 . 2008 . Haig . David M. . Grant . Dawn . Deane . David . Campbell . Iris . Thomson . Jackie . Jepson . Catherine . Buxton . David . Russell . George C..
  26. Web site: NADIS Animal Health Skills - Malignant Catarrhal Fever (MCF). www.nadis.org.uk. 2019-04-02.
  27. Book: OIE . OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals . 5th . France . 570–579.
  28. Web site: Carter, G.R. . Flores, E.F. . Wise, D.J. . 2006 . Herpesviridae . A Concise Review of Veterinary Virology . 2006-06-10.
  29. Web site: Overview of Malignant Catarrhal Fever - Generalized Conditions. Merck Veterinary Manual. en-US. 2019-04-02.
  30. 10.1016/j.vetmic.2006.03.002. 16621342. Development of an enzyme-linked immunosorbent assay for the detection of antibodies against malignant catarrhal fever viruses in cattle serum. Veterinary Microbiology. 116. 1–3. 21–28. 2006. Fraser. S.J.. Nettleton. P.F.. Dutia. B.M. Haig. D.M.. Russell. G.C..
  31. 10.1177/104063870101300417. 11478614. A Simpler, More Sensitive Competitive Inhibition Enzyme-Linked Immunosorbent Assay for Detection of Antibody to Malignant Catarrhal Fever Viruses. Journal of Veterinary Diagnostic Investigation. 13. 4. 361–364. 2001. Li. Hong. McGuire. Travis C.. Müller-Doblies. Uwe U.. Crawford. Timothy B.. free.
  32. 10.1128/JCM.00997-09. 19494077. Development of a Multiplex Real-Time PCR for Detection and Differentiation of Malignant Catarrhal Fever Viruses in Clinical Samples. Journal of Clinical Microbiology. 47. 8. 2586–2589. 2009. Cunha. C. W.. Otto. L.. Taus. N. S.. Knowles. D. P.. Li. H.. 2725674.
  33. 10.1177/104063870701900412. 17609352. Validation of Nonnested and Real-Time PCR for Diagnosis of Sheep-Associated Malignant Catarrhal Fever in Clinical Samples. Journal of Veterinary Diagnostic Investigation. 19. 4. 405–408. 2007. Traul. Donald L.. Taus. Naomi S.. Oaks. J. Lindsay. Toole. Donal O'. Rurangirwa. Fred R.. Baszler. Timothy V.. Li. Hong. free.
  34. 18156595. 2007. Bexiga. R.. Clinical differentiation of malignant catarrhal fever, mucosal disease and bluetongue. The Veterinary Record. 161. 25. 858–9. Guyot. H.. Saegerman. C.. Mauroy. A.. Rollin. F.. Thiry. E.. Philbey. A. W.. Logue. D. N.. Mellor. D. J.. Barrett. D. C.. Ellis. K..
  35. Li . Hong . Cunha . Cristina W. . Taus . Naomi S. . Knowles . Donald P. . Malignant Catarrhal Fever: Inching Toward Understanding . . . 2 . 1 . 2014-02-01 . 2165-8102 . 10.1146/annurev-animal-022513-114156 . 209–233. 25384141 .
  36. Web site: Figuring Out Puzzling Animal Diseases . July 9, 2017 . https://web.archive.org/web/20100405072452/http://www.ars.usda.gov/is/AR/archive/apr10/animal0410.htm . 2010-04-02 . 2010-04-05 . USDA Agricultural Research Service .